WARNING!
This is an older article that may not reflect Dr. Mercola’s current view on this topic. Use our search engine to find Dr. Mercola’s latest position on any health topic.
Drugmaker Pfizer is pulling Mylotarg, a decade-old leukemia medicine, off the U.S. market after a study found a higher death rate and no benefit for patients.
Mylotarg won approval under an abbreviated process. Medicines cleared in that way have to pass follow-up tests to confirm they work. The FDA asked Pfizer to withdraw the drug after a recent clinical trial raised concerns about the product's safety and clinical benefits.